You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 7, July 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Maintenance of Replicative Intermediates in Ganciclovir-Treated Human Cytomegalovirus—Infected Retinal Glia

Eileen M. Burd, PhD; Jose S. Pulido, MD, MS; Donald G. Puro, MD, PhD; William J. O'Brien, PhD

Arch Ophthalmol. 1996;114(7):856-861.


Abstract

Objectives
To characterize the molecular structure of the human cytomegalovirus (HCMV) DNA maintained in cultures of human retinal glia following ganciclovir treatment and to determine the biological activity of the DNA.

Methods
Cultures of human retinal glia were established, infected with HCMV, treated with ganciclovir, and embedded in agarose, and the viral DNA was analyzed by field inversion gel electrophoresis.

Results
The HCMV DNA was found to persist in cultures of infected, ganciclovir-treated retinal glial cells in the form of replicative intermediates. After removal of ganciclovir, processed forms of DNA in the 500- to 1000-kilobase range were found as well as 230-kb unit length genome. Infectious virus was recovered after termination of ganciclovir treatment.

Conclusion
The data are consistent with the concept that ganciclovir's virostatic nature permits maintenance of HCMV DNA in retinal glia in a biologically active form that is capable of replication after removal of the drug.



Author Affiliations

From the Department of Ophthalmology, Medical College of Wisconsin, Milwaukee (Drs Burd, Pulido, and O'Brien); the Department of Pathology, Henry Ford Hospital, Detroit, Mich (Dr Burd); and the Departments of Ophthalmology and Physiology, University of Michigan, Ann Arbor (Dr Puro). The authors have no financial interest and received no consultant fees for products described in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Visual symptoms in patients on cyclophosphamide may herald sight threatening disease
Agrawal et al.
Br J Ophthalmol 2003;87:122-123.
FULL TEXT  

Immune Recovery Vitritis in HIV Infection: Abstracts and Commentary
Dunn
JAMA 1998;280:185-186.
FULL TEXT  

Acquired Immunodeficiency Syndrome and the Eye--1996
Jabs
Arch Ophthalmol 1996;114:863-866.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.